{
      "ptx_code": "PTX126",
      "chem_name": "Anastrozole",
      "casrn": "120511-73-1",
      "dtxsid": "DTXSID9022607",
      "smiles": "CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N",
      "inchikey": "YBBLVLTVTVSKRW-UHFFFAOYSA-N",
      "label": "PTX126 | Anastrozole",
      "drugbank_id": "DB01217",
      "use_class": "Pharmaceutical",
      "tox_class": "Hepatotoxicity; Nephrotoxicity; Genotoxicity; Cardiotoxicity",
      "chem_name_user": "Anastrozole",
      "mw_g_mol": "293.374",
      "solubility_h2o_mol_liter": "0.000416719",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "3.90099e-06",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "3.79713483481249",
      "source_kaw": "LSER",
      "pka_acid": "",
      "pka_base": "1.21",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "2.5225",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "2.66772498443937",
      "source_dlipw": "Kow-QSAR (\u00e2\u02c6\u2020mw=1)",
      "freely_dissolved_fraction": "0.657805175706962",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "baseline_drerio": "379.273295629466",
      "baseline_dmagna": "219.512882516493",
      "baseline_celegans": "480.341392374143",
      "baseline_xlaevis": "180.948574860166",
      "baseline_dmelanogaster": "1913.20166577817",
      "baseline_cells": "8.49475929383332e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "5.58789662986838e-05",
      "moa_drugbank": "Anastrazole exerts its anti-estrogenic effects via selective and competitive inhibition of the aromatase enzyme found predominantly in the adrenal glands, liver, and fatty tissues.[A186877] Many breast cancers are hormone receptor-positive, meaning their growth is stimulated and/or maintained by the presence of hormones such as estrogen or progesterone.[L8863] In postmenopausal women, estrogen is primarily derived from the conversion of adrenally-produced androgens into estrogens by the aromatase enzyme - by competitively inhibiting the biosynthesis of estrogen at these enzymes, anastrozole effectively suppresses circulating estrogen levels and, subsequently, the growth of hormone receptor-positive tumours.[A186877,A186958]",
      "protein_binding": "Anastrozole is 40% protein bound in plasma[L8863] and appears to be independent of plasma concentration.[L8869]",
      "moa_t3db": "",
      "aop": [],
      "targets": [
            "Cytochrome P450 19A1",
            "Estrogen receptor alpha"
      ]
}